2. Academic Validation
  3. miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway

miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway

  • Biochem Biophys Res Commun. 2020 Nov 12;532(3):329-335. doi: 10.1016/j.bbrc.2020.05.135.
Xiao-Yan Wang 1,  Yi-Chan Zhou 2,  Yan Wang 1,  Yun-Yun Liu 1,  Yu-Xin Wang 1,  Dan-Dan Chen 1,  Yu Fan 3
Affiliations

Affiliations

  • 1 Department of Gastroenterology, The First People's Hospital of Suqian, Su'qian, Jiangsu, 223800, China.
  • 2 Jiangsu Provincial Key Laboratory of Geriatrics, Department of Geriatrics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210006, China.
  • 3 Cancer Institute, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212002, China. Electronic address: [email protected].
PMID: 32977944 DOI: 10.1016/j.bbrc.2020.05.135
Abstract

Drug resistance remains the unresolved obstacle for gastric Cancer (GC) treatment. Recently more and more studies have shown that MicroRNAs are involved in Cancer resistance and could apply to drug resistance therapy in tumors. The relationship between miR-149 and 5-fluorouracil (5-FU) resistance in GC remains unclear. Here we detected miR-149 expression in 5-FU resistance tumor tissues and cell lines, and found that miR-149 expression is upregulated in AGS/5-FU cells compared with AGS cells. Further experiments indicated that overexpression of miR-149 can alleviate 5-FU-induced Apoptosis and proliferation inhibition by targeting TREM2. It was also confirmed that TREM2 regulated 5-FU resistance through β-catenin pathway. Generally speaking, our results indicated that miR-149 contributes to resistance of 5-FU in gastric Cancer via targeting TREM2 and regulating β-catenin pathway.

Keywords

5-FU; Drug resistance; Gastric cancer; miR-149.

Figures
Products